Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 36


Colon Capsule Endoscopy for the Detection of Colorectal Polyps: An Economic Analysis.

Palimaka S, Blackhouse G, Goeree R.

Ont Health Technol Assess Ser. 2015 Jul 1;15(15):1-43. eCollection 2015.


Modeling Disease Progression with Longitudinal Markers.

Inoue LY, Etzioni R, Morrell C, Müller P.

J Am Stat Assoc. 2008;103(481):259-270.


Review of economic evidence in the prevention and early detection of colorectal cancer.

Jeong KE, Cairns JA.

Health Econ Rev. 2013 Sep 12;3(1):20. doi: 10.1186/2191-1991-3-20.


Chapter 10: deciding whether to complement a systematic review of medical tests with decision modeling.

Trikalinos TA, Kulasingam S, Lawrence WF.

J Gen Intern Med. 2012 Jun;27 Suppl 1:S76-82. doi: 10.1007/s11606-012-2019-3.


Contribution of screening and survival differences to racial disparities in colorectal cancer rates.

Lansdorp-Vogelaar I, Kuntz KM, Knudsen AB, van Ballegooijen M, Zauber AG, Jemal A.

Cancer Epidemiol Biomarkers Prev. 2012 May;21(5):728-36. doi: 10.1158/1055-9965.EPI-12-0023. Epub 2012 Apr 18.


Impact of comorbidity on colorectal cancer screening cost-effectiveness study in diabetic populations.

Dinh TA, Alperin P, Walter LC, Smith R.

J Gen Intern Med. 2012 Jun;27(6):730-8. doi: 10.1007/s11606-011-1972-6. Epub 2012 Jan 12. Review.


Managed care and the diffusion of endoscopy in fee-for-service Medicare.

Mobley LR, Subramanian S, Koschinsky J, Frech HE, Trantham LC, Anselin L.

Health Serv Res. 2011 Dec;46(6pt1):1905-27. doi: 10.1111/j.1475-6773.2011.01301.x. Epub 2011 Aug 16.


Comparative economic evaluation of data from the ACRIN National CT Colonography Trial with three cancer intervention and surveillance modeling network microsimulations.

Vanness DJ, Knudsen AB, Lansdorp-Vogelaar I, Rutter CM, Gareen IF, Herman BA, Kuntz KM, Zauber AG, van Ballegooijen M, Feuer EJ, Chen MH, Johnson CD.

Radiology. 2011 Nov;261(2):487-98. doi: 10.1148/radiol.11102411. Epub 2011 Aug 3.


How much colonoscopy screening should be recommended to individuals with various degrees of family history of colorectal cancer?

Wilschut JA, Steyerberg EW, van Leerdam ME, Lansdorp-Vogelaar I, Habbema JD, van Ballegooijen M.

Cancer. 2011 Sep 15;117(18):4166-74. doi: 10.1002/cncr.26009. Epub 2011 Mar 8.


Eight years of colonoscopic bowel cancer screening in Germany: initial findings and projections.

Brenner H, Altenhofen L, Hoffmeister M.

Dtsch Arztebl Int. 2010 Oct;107(43):753-9. doi: 10.3238/arztebl.2010.0753. Epub 2010 Oct 29.


Stool DNA testing to screen for colorectal cancer in the Medicare population: a cost-effectiveness analysis.

Lansdorp-Vogelaar I, Kuntz KM, Knudsen AB, Wilschut JA, Zauber AG, van Ballegooijen M.

Ann Intern Med. 2010 Sep 21;153(6):368-77. doi: 10.7326/0003-4819-153-6-201009210-00004.


Simulation of colorectal cancer screening: what we do and do not know and does it matter.

van Ballegooijen M, Boer R, Zauber AG.

Best Pract Res Clin Gastroenterol. 2010 Aug;24(4):427-37. doi: 10.1016/j.bpg.2010.07.001.


Community contextual predictors of endoscopic colorectal cancer screening in the USA: spatial multilevel regression analysis.

Mobley LR, Kuo TM, Urato M, Subramanian S.

Int J Health Geogr. 2010 Sep 3;9:44. doi: 10.1186/1476-072X-9-44.


Cost-effectiveness of colorectal cancer screening in high-risk Spanish patients: use of a validated model to inform public policy.

Ladabaum U, Ferrandez A, Lanas A.

Cancer Epidemiol Biomarkers Prev. 2010 Nov;19(11):2765-76. doi: 10.1158/1055-9965.EPI-10-0530. Epub 2010 Sep 1.


Hospital costs of colorectal cancer care.

Macafee DA, West J, Scholefield JH, Whynes DK.

Clin Med Oncol. 2009 Mar 20;3:27-37.


Prevention, screening and treatment of colorectal cancer: a global and regional generalized cost effectiveness analysis.

Ginsberg GM, Lim SS, Lauer JA, Johns BP, Sepulveda CR.

Cost Eff Resour Alloc. 2010 Mar 17;8:2. doi: 10.1186/1478-7547-8-2.


Performance value of high risk factors in colorectal cancer screening in China.

Meng W, Cai SR, Zhou L, Dong Q, Zheng S, Zhang SZ.

World J Gastroenterol. 2009 Dec 28;15(48):6111-6.


Effect of rising chemotherapy costs on the cost savings of colorectal cancer screening.

Lansdorp-Vogelaar I, van Ballegooijen M, Zauber AG, Habbema JD, Kuipers EJ.

J Natl Cancer Inst. 2009 Oct 21;101(20):1412-22. doi: 10.1093/jnci/djp319. Epub 2009 Sep 24.


Calibration methods used in cancer simulation models and suggested reporting guidelines.

Stout NK, Knudsen AB, Kong CY, McMahon PM, Gazelle GS.

Pharmacoeconomics. 2009;27(7):533-45. doi: 10.2165/11314830-000000000-00000. Review.

Items per page

Supplemental Content

Write to the Help Desk